According to Twist Bioscience 's latest financial reports and stock price the company's current Operating Margin is -59.57%. At the end of 2024 the company had an Operating Margin of -66.51%.
Year | Operating Margin | Change |
---|---|---|
2024 | -66.51% | -19.87% |
2023 | -83.01% | -25.97% |
2022 | -112.14% | -3.66% |
2021 | -116.39% | -24.85% |
2020 | -154.88% | -21.55% |
2019 | -197.44% | -29.29% |
2018 | -279.21% | -49.07% |
2017 | -548.25% | -71.78% |
2016 | -1,943.06% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() | -19.96% | -66.49% | Jersey |
![]() | -25.89% | -56.54% | ๐บ๐ธ USA |
![]() | -10,150.00% | 16,938.78% | ๐บ๐ธ USA |
![]() | -129.00% | 116.55% | ๐ฌ๐ง UK |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.